期刊文献+

3D打印技术在心脏结构性疾病中的应用

Application of 3D printing technique in cardiac structural diseases
原文传递
导出
摘要 3D打印技术近年来逐渐应用于医学研究中,为许多疾病的治疗带来希望。尤其是在心脏结构性疾病中的应用,从协助诊断到指导治疗,以及心脏结构性疾病发病机制的研究,意义越来越突出。3D打印的过程包括成像数据的采集、图像数据的处理、模型打印3个步骤。现对3D打印技术在心脏结构性疾病中的应用作以下论述。 3D printing technology in recent years gradually applied to medical research,and brought hope to the treatment of many diseases.Particularly 3D printing technology was used in the structural heart disease,which became more and more prominent from the help of diagnosis to guide the treatment.3D printing process includes imaging data acquisition,postprocessing of image data and printing model.This paper discusses the application of 3D printing technology in the structural heart disease.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2017年第11期1036-1040,共5页 Journal of Clinical Cardiology
基金 河北省大学生创新训练项目基金(No:201610075036)
关键词 3D打印 成型技术 心脏结构性疾病 教育 3D print molding technology structural heart disease education
  • 相关文献

参考文献2

二级参考文献15

  • 1Georgios K Efthimiadis,Efstathios D Pagourelias,Thomas Gossios,Thomas Zegkos.WJC 6~th Anniversary Special Issues(3):Cardiomyopathy Hypertrophic cardiomyopathy in 2013:Current speculations and future perspectives[J].World Journal of Cardiology,2014,6(2):26-37. 被引量:9
  • 2MARON B J,MARON M S.Hypertrophic cardiomyopathy[J].Lancet 2013;381:242-255.
  • 3QIN J X,SHIOTA T,LEVER H M,et al.Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery[J].J Am Coll Cardiol,2001,38:1994-2000.
  • 4WENGER N K,SPEROFF L,PACKARD B.Cardiovascular health and disease in women[J].N Engl J Med,1993,329:247-256.
  • 5ZHANG W,LI Z,ZHANG M,et al.Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy[J].Chin Med J(Engl),2002,115:1283-1286.
  • 6LI Z Q,CHENG T O,ZHANG W W,et al.Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy;The Chinese experience in 119patients from a single center[J].Int J Cardiol,2004,93:197-202.
  • 7PRINZ C,FARR M,HERING D,et al.The diagnosis and treatment of hypertrophic cardiomyopathy[J].Dtsch Arztebl Int,2011,108:209-215.
  • 8PEREZ-LOPEZ F R,CHEDRAUI P,GILBERT J J,et al.Cardiovascular risk in menopausal women and prevalent related co-morb id conditions:facing the post-Women's Health Initiativeera[J].Fertil Steril,2009,92:1171-1186.
  • 9CIGNARELLA A,KRATZ M,BOLEGO C.Emerging role of estrogen in the control of cardiometabolic disease[J].Trends Pharmacol Sci,2010,31:183-189.
  • 10TOLBERT T,OPARIL S.Cardiovascular effects of estrogen[J].Am J Hypertens,2001,14:186S-193S.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部